Patent · US Active

(Heterocycle/condensed piperidine)-(piperazinyl)-1-alkanone or (heterocycle/condensed pyrrolidine)-(piperazinyl)-1-alkanone derivatives and use thereof as p75 inhibitors

US8580790B2 · kind B2 · utility

5Cited by

5References

30Claims

0Family size

Assignee

Sanofi · FR

Inventors

Marco Baroni · Mantova, IT
Francoise Bono · Paris, FR
Sandrine Delbary-Gossart · Mauzac, FR
Valentina Vercesi · Pavia, IT

Key dates

Filing date	Jun 7, 2012
Grant date	Nov 12, 2013
Priority date	—
Expiry date	Jun 7, 2032

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D513/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The disclosure relates to (heterocycle-fused piperidine)-(piperazinyl)-1-alkanone derivatives and (heterocycle-fused pyrrolidine)-(piperazinyl)-1-alkanone derivatives of formula (I):wherein A, W, R2 and n are as defined in the disclosure, to the method of preparation thereof and the therapeutic use thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.